Laminated body support element

Details for Australian Patent Application No. 2004289540 (hide)

Owner Lancastria Limited

Inventors Woolfson, David; Hackett, Padraig

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004289540

PCT Pub. Number WO2005/046988

Priority S2003/0849 12.11.03 IE

Filing date 12 November 2004

Wipo publication date 26 May 2005

International Classifications

A47C 27/14 (2006.01) Stuffed or fluid mattresses specially adapted for chairs, beds or sofas - with foamed material inlays

B32B 5/08 (2006.01) Layered products characterised by the non-homogeneity or physical structure of a layer - the fibres or filaments of a layer being specially arranged or being of different substances

B32B 5/18 (2006.01) Layered products characterised by the non-homogeneity or physical structure of a layer - characterised by features of a layer containing foamed or specifically porous material

B32B 27/12 (2006.01) Layered products essentially comprising synthetic resin - next to a fibrous or filamentary layer

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/046988 Priority application(s): WO2005/046988

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289544-A multi-layered tile or block

2004289539-Aryl imidazoles and their use as anticancer agents